Dynavax Technologies (DVAX)
(Delayed Data from NSDQ)
$10.46 USD
-0.03 (-0.29%)
Updated Oct 28, 2025 04:00 PM ET
After-Market: $10.46 0.00 (0.00%) 5:18 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Dynavax Technologies Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
DVAX 10.46 -0.03(-0.29%)
Will DVAX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for DVAX based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for DVAX
Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last?
Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates
DVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates
Exelixis (EXEL) Beats Q2 Earnings Estimates
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why
Other News for DVAX
Is DVAX set to rally? Stochastic Reached Overbought shows up after rising 1.06%
Dynavax Technologies Advances in Pneumonic Plague Vaccine Study
DVAX forms Bollinger Band Squeeze on October 24
DVAX forms 50 Day Moving Average Support on October 23
50 Day Moving Average Support appears for DVAX after 0.3% move